Lonza Group Ltd (LZAGY)
62.99
+1.32
(+2.14%)
USD |
OTCM |
Nov 01, 16:00
Lonza Group Total Assets (Quarterly): 19.89B for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 19.89B |
| June 30, 2024 | 19.89B |
| December 31, 2023 | 20.06B |
| June 30, 2023 | 19.65B |
| June 30, 2023 | 19.65B |
| December 31, 2022 | 18.72B |
| June 30, 2022 | 17.54B |
| June 30, 2022 | 17.54B |
| December 31, 2021 | 18.01B |
| June 30, 2021 | 16.46B |
| June 30, 2021 | 16.46B |
| December 31, 2020 | 16.52B |
| June 30, 2020 | 14.66B |
| June 30, 2020 | 14.66B |
| December 31, 2019 | 14.28B |
| June 30, 2019 | 13.81B |
| June 30, 2019 | 13.81B |
| December 31, 2018 | 14.14B |
| June 30, 2018 | 14.04B |
| June 30, 2018 | 14.04B |
| December 31, 2017 | 14.20B |
| June 30, 2017 | 10.04B |
| June 30, 2017 | 10.04B |
| Date | Value |
|---|---|
| December 31, 2016 | 6.737B |
| June 30, 2016 | 6.422B |
| June 30, 2016 | 6.422B |
| December 31, 2015 | 6.321B |
| June 30, 2015 | 6.524B |
| June 30, 2015 | 6.524B |
| December 31, 2014 | 6.514B |
| June 30, 2014 | 7.406B |
| June 30, 2014 | 7.406B |
| December 31, 2013 | 7.181B |
| June 30, 2013 | 7.408B |
| June 30, 2013 | 7.408B |
| December 31, 2012 | 7.714B |
| June 30, 2012 | 7.265B |
| June 30, 2012 | 7.265B |
| December 31, 2011 | 7.477B |
| June 30, 2011 | 5.291B |
| December 31, 2010 | 5.112B |
| June 30, 2010 | 4.617B |
| December 31, 2009 | 4.774B |
| June 30, 2009 | 5.009B |
| December 31, 2008 | 5.264B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
14.28B
Minimum
Dec 2019
20.06B
Maximum
Dec 2023
17.60B
Average
17.54B
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| AC Immune SA | 264.24M |
| CRISPR Therapeutics AG | 2.340B |
| Addex Therapeutics Ltd | 15.24M |
| NLS Pharmaceutics Ltd | 1.194M |
| Molecular Partners AG | 189.80M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.422B |
| Shareholders Equity (Quarterly) | 10.40B |
| Debt to Equity Ratio | 0.4058 |
| Current Ratio | 2.042 |
| Net Debt Paydown Yield | -1.54% |